KNSA KINIKSA PHARMACEUTICALS INTERNATIONAL PLC Investments/Divestments 8-K Filing 2024 - Agreement with Samsung Biologics Kiniksa Pharmaceuticals, Ltd. entered into a Master Services Agreement and Product Specific Agreement with Samsung Biologics Co., Ltd. for the supply of their drug substance ARCALYST.Get access to all SEC 8-K filings of the KINIKSA PHARMACEUTICALS INTERNATIONAL PLC